Medicine & Health

Patients with social needs had a higher number of hospitalizations, obesity, prediabetes and Type 2 diabetes, finds a new study from the Brown School on the social determinants of health.

The Brown School’s Vetta Sanders Thompson has spent much of her career focused on racial identity, diversity and health.

Fred Ssewamala and his research team here and in Uganda are creating and implementing poverty alleviation and public health interventions that are making a huge difference in the lives of children, families and communities in the African country.

A deep dive by researchers at Washington University School of Medicine and the Brown School found gaping health disparities resulting from the COVID-19 pandemic. The study, which looked at St. Louis County residents, shows that Black women suffered disproportionately higher rates of employment loss and food insecurity.

A new study from Washington University School of Medicine and the Veterans Affairs St. Louis Health Care system found that repeat SARS-CoV-2 infections contribute significant additional risk of adverse health conditions in multiple organ systems.

Lindsay Stark, a professor at the Brown School, has received a one-year $435,000 grant from UNICEF for a project titled “Intervention Review and Implementation Research to Address Gender-based Violence in Emergencies.”

The U.S. Department of Health and Human Services has awarded researchers Ellen Fitzsimmons-Craft and Denise Wilfley a grant to help improve outcomes for eating disorders in adolescent girls.

Research from the lab of Brian Carpenter, in Arts & Sciences, suggests older adults understood that sometimes-unflattering COVID-19 messaging came from a place of caring and compassion.

Research from the lab of Fangqiong Ling at the McKelvey School of Engineering finds SARS-CoV-2 material in wastewater reflects illnesses in communities. It also helps establish guidance for future studies.

Washington University has licensed the rights to develop, manufacture and commercialize its proprietary COVID-19 nasal vaccine in the United States, Europe and Japan to Ocugen Inc., a U.S.-based biotechnology company.